HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Production and Characterization of Concentrated and Purified RSV and MVM Virus Stocks per the attached Combined Synopsis Solicitation FDA-CSS-1228355. | Type: Combined Synopsis/Solicitation | Sol#: FDA-CSS-1228355
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
AMENDMENT 1 to FDA-RFP-1223623 ( Support for the Establishment and Operation of a Center of Excellence for Engagement with Compounding Outsourcing Facilities ) The purpose of Amendment 1 to FDA-RFP-1 | Type: Combined Synopsis/Solicitation | Sol#: FDA-RFP-1223623
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Amendment A00001, 07/21/2020: Date and time for submission of proposals has been extended to no later than (NLT) 4 pm Central Time August 7, 2020. See attached solicitation files for the FDA's requirement for a Trans | Type: Combined Synopsis/Solicitation | Sol#: FDA-RFP-1223854
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The purpose of Amendment 1 is to: 1. Respond to Questions Received. (Please see attachment Amendment 1 - Responses to Questions Recieved). 2. Update the RFQ (Please see document titled Amendment 1). 3. Extend the due date f | Type: Combined Synopsis/Solicitation | Sol#: 1225254
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Amendment Two: See attached Amendment 0002 75F4012Q00075 for Correction of Typographical error with Question and Answers. PROPOSAL DUE : All Volumes for the quotes are due, electronically through email to Patricia.Natividad | Type: Combined Synopsis/Solicitation | Sol#: 75F40120Q00075
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
The U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), has a requirement for a Transfusion-Transmissible Infection (TTI) Monitoring System (TTIMS) Laboratory and R | Type: Combined Synopsis/Solicitation | Sol#: FDARF
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA CENTER FOR DRUG EVALUATION AND RESEARCH
Please see attached soliciration for details | Type: Combined Synopsis/Solicitation | Sol#: 1249290
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FOOD AND DRUG ADMINISTRATION
Evaluate Plastic Residues in Animal Foods from Human Food By-Product Processing Proposals should include that this contract specifies using a small-scale human food by-product processing system (hereafter referred to as th | Type: Combined Synopsis/Solicitation | Sol#: FDA-22-RFQ-1251882
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
See Attached Combined Synopsis/Solicitation FDA_22-223-1255173 | Type: Combined Synopsis/Solicitation | Sol#: FDA_22-223-1255173
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
See Attached Combined Synopsis/Solicitation FDA_22-223-NCTR-2022-112773 | Type: Combined Synopsis/Solicitation | Sol#: FDA_22-223-NCTR-2022-11277
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH
See attached solicitation 75F40122Q1252857 (.PDF file) and Attachment 1 List of Equipment (.xls file). | Type: Combined Synopsis/Solicitation | Sol#: 75F40122Q1252857
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
See Attached Combined Synopsis/Solicitation FDA_22-223- NCTR-2022-112773 | Type: Combined Synopsis/Solicitation | Sol#: FDA_22-223-NCTR-2022-112773
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The Contractor shall be capable of providing both the Service Agreement and Qualification Service for the system specified in the Statement of Work to ensure uninterrupted performance within manufacturer’s specification. Minimum P | Type: Combined Synopsis/Solicitation | Sol#: FDA-RFQ-22-1254600
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF REGULATORY AFFAIRS
Please see the attached RFQ document. | Type: Combined Synopsis/Solicitation | Sol#: FDA-23-RFQ-117376
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA Office of Acquisitions and Grants Services
Amendment 2- As additional clarification, this is a full and open solicitation with no set aside. However, any size bussiness may submit a proposal. Amendment 1 - Added all Questions asked of and answered by the Government. < | Type: Combined Synopsis/Solicitation | Sol#: FDA-RFP-23-115584
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Request for Quotation : 75F401-23-Q- 1263930 Response Date: Date: April 26, 2023, 3:00 p.m. Eastern Time. NOTE: Please indicate company’s SAM.gov Unique Entity ID on the quot | Type: Combined Synopsis/Solicitation | Sol#: 75F401-23-Q-1263930
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
See Attached Combined Synopsis/Solicitation and Required Submission of Attached FDA FORM 3398 | Type: Combined Synopsis/Solicitation | Sol#: FDA-NCTR-2023-118263
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Amendment 00001 - extend the RFQ due date to 5/24/2023, 3:30 pm and extend questions due by date to 05/17/2023, 3:00 pm Solicitation number 75F40123Q00191 is issued as a Request for Quotation (RFQ). This is a combined synopsis/s | Type: Combined Synopsis/Solicitation | Sol#: 75F40123Q00191
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The Food and Drug Administration’s Center for Drug Evaluation and Research has a need for access to National Drug Code (NDC) Level Information Data. See Attachment. 6/22/2023: The purpose of this modification is the fol | Type: Combined Synopsis/Solicitation | Sol#: FDA-RFP-75F40123R00085
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
FDA needs a commercial contractor to provide a total of 1-2 sessions of the above course in a fully virtual or in-person format for four days for up to 50 adult learners to support their learning and development needs. This scope consists of four | Type: Combined Synopsis/Solicitation | Sol#: 75F401
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Use of tobacco products expose the consumer to a variety of harmful and potentially harmful constituents (HPHCs) and other toxic chemicals that commonly result in the occurrence of adverse health outcomes. These HPHCs and other toxic chemicals may | Type: Combined Synopsis/Solicitation | Sol#: 75F40
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA CENTER FOR DRUG EVALUATION AND RESEARCH
IDIQ Contract for FDA wide scientific support services. See Attachments for RFP 9/15/2023: Modification #1: Contractor Questions and Government Responses - See Attachment - Attachment No. 10 - Questions- Government Re | Type: Combined Synopsis/Solicitation | Sol#: 75F40123R00132
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Please See Attached Combined Synopsis Solicitation | Type: Combined Synopsis/Solicitation | Sol#: FDA_24-223-121741
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Amendment No. 1 Proposals due date is changed to April 26, 2024, 3:00 PM Eastern Time or sooner. __________________________________________________________________ < | Type: Combined Synopsis/Solicitation | Sol#: FDA24RFQ75F40124R0005
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
6/21/24: Amendment 2: See attached Amendment 2. 6/14/2024: Amendment 1: Solicitation response date for receipt of quotes is extended until 1:00PM Central Time on June 20, 2024. See attached combined synopsis/solicitation. | Type: Combined Synopsis/Solicitation | Sol#: 75F40124Q123503
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA CENTER FOR DRUG EVALUATION AND RESEARCH
Program Management Organization (PMO) contract for Sentinel 3.0 that will provide program/project management and business informatics support services. Indefinite Delivery Indefinite Quantity (IDIQ) Contract with Time and Materia | Type: Award Notice | Sol#: RFP75F40124R00181
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The overall scope of the project is to have a contract laboratory purchase and test ~70 aqueous OTC monograph drug product samples for microbial contamination using compendial test methods during the period of performance. These OTC drug products | Type: Combined Synopsis/Solicitation | Sol#: FDA-CD
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The Center for Tobacco Product (CTP) Tobacco Products Laboratory (TPL) located in Atlanta, Georgia has a requirement for a service and qualification agreement for a Cerulean CETI-8 Electronic Cigarette (E-Cigarette) Smoking Machine. | Type: Combined Synopsis/Solicitation | Sol#: RFQ_2025127285OC
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA CENTER FOR DRUG EVALUATION AND RESEARCH
Amendment 1: The purpose of this amendment is to provide the answers to questions received. -------------------------------------------------------------------------------------------------------------------------------- Background | Type: Combined Synopsis/Solicitation | Sol#: 75F40125Q00401
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Please be aware, Solicitation Amendment 1 revises the Solicitation body and Attachment 2 - Statement of Work. ________________________________________________________________________________________________________ | Type: Combined Synopsis/Solicitation | Sol#: 75F40124Q00508
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF THE COMMISSIONER
Amendment 0004 - Solicitation period extended to 01 Sep 2022. All other terms and conditions remain the same. ALL attachments are embedded in the PDF file under the attachments tab on the left (paperclip Icon). Amend | Type: Combined Synopsis/Solicitation | Sol#: 75F40122R00065
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The purpose of Amendment # 2 is to do the following: To provide the responses to questions via attachment labeled, Attachment 2- Questions and Answers. All other terms and conditions remain unchanged. 5/12/2020. | Type: Combined Synopsis/Solicitation | Sol#: FDA-RFP-1224045
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The purpose of Amendment # 2 is to do the following: To provide the responses to questions via attachment labeled, Attachment 2- Questions and Answers. All other terms and conditions remain unchanged. 5/13/2020. | Type: Combined Synopsis/Solicitation | Sol#: FDA-RFP-1224105
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Type: Award Notice | Sol#: FDA-20-RFQ-1224159
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Amenment No: 2 - Updated Attachment 1 - Past Performance Questionnaire (Revised) - July 27, 2020 Only change in the form is updated closing date as 7/30/2020 . All others remain same. ******************************* | Type: Combined Synopsis/Solicitation | Sol#: FDA-RFP-1226927
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Sole Source Award Notice: Sermo, Inc. Sermo is the only platform that provides both of the 2 key types of data collection that Center for Drug Evaluations and Research (CDER), Office of Communications (OCOMM) researchers need: 1) | Type: Combined Synopsis/Solicitation | Sol#: FDA-20-SS-1230437
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
RFP for Collecting Nutritional Data for the Top 100 Restaurants Amendment 1 Collecting Nutrition Data for the Top 100 Restaurants Q & A Collecting Nutrition Data for the Top 100 Restaurants Q & A Collecting Nutritio | Type: Combined Synopsis/Solicitation | Sol#: FDA-20-RFQ-1229307
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Amendment No: 1 See enclosed Attachement No: 2 - Questions & Answers. Issued date September 11, 2020 _____________________________________________________________________________ The U.S. Food and Drug Administration&rs | Type: Combined Synopsis/Solicitation | Sol#: FDA-RFP-1227066
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Updated 03/01/2021. An amendment to RFP Number: FDA-SOL-1234457, “Evaluation of the Center for Tobacco Products Public Education Campaigns, Communication Programs and Channels” has been posted. Please see the attachments s | Type: Combined Synopsis/Solicitation | Sol#: FDA-SOL-1234457
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA Office of Acquisitions and Grants Services
RFQ Collecting Nutrition Data for Top 100 Restaurant Chains EXTENDING RESPONSE DATE TO 03/29/2021 AT 5PM EST Amendment 1 Collection Nutrition Data for Top Restaurant Chains Questions and Answers Amendment 2 Collecti | Type: Combined Synopsis/Solicitation | Sol#: FDA-21-RFQ-1238727
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA CENTER FOR TOBACCO PRODUCTS
Please see the attached solicitationfor details | Type: Combined Synopsis/Solicitation | Sol#: FDA-21-SOL-1238617
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA CENTER FOR TOBACCO PRODUCTS
See Attachments for RFQ and Pricing Schedule. See Attachment for Contractor questions and Government Responses | Type: Combined Synopsis/Solicitation | Sol#: FDARFQ1238678
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF THE COMMISSIONER
This is Amendment No. 00001 to the Combined Synopsis/Solicitation to provide answers to the questions submitted. I also revises the soliciation to make corrections to the number of distributions required (see the yellow highlighted areas in | Type: Combined Synopsis/Solicitation | Sol#: FDA-21-RFQ-
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA CENTER FOR TOBACCO PRODUCTS
RFP for Assessment of Nicotine Dose Discrimination in Marketed Cigarettes Response date changed to 03/06/2020 at 5pm est Amendment 2-Changes in red Amendment 3-Add subcontracting plan, change in red and Q & A Q | Type: Combined Synopsis/Solicitation | Sol#: FDA-20-RFP-1223088
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The U. S. Food and Drug Administration (FDA) has a need for the procurement to recruit patients who were diagnosed with mild or moderate traumatic brain injury within 6 months, who are experiencing chronic pain requiring consistent pain control me | Type: Combined Synopsis/Solicitation | Sol#: RFQ-7
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA Office of Acquisitions and Grants Services
Questions due 10AM EST 10/27/2021 Proposal due 10AM EST 11/11/2021 When Submitting question and proposals, please include in the subject line " FDA-RFP-20-1236379" An amendment was done on | Type: Combined Synopsis/Solicitation | Sol#: fda-20-1236379
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The Food and Drug Administration (FDA), Center for Tobacco Products (CTP) requires a contractor to provide microbiological analyses of the following parameters in electronic nicotine delivery systems (ENDS) e-liquids: water activity | Type: Combined Synopsis/Solicitation | Sol#: 75F4012R00023
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
The primary objective of this project is to conduct multiple CUHF studies of complex drug-device combination products in relevant populations (e.g., patients and/or caregivers and/or health care providers) to assess the impact of “other&rdqu | Type: Combined Synopsis/Solicitation | Sol#: 75F40123R00
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
Reports of the sample analysis and results of relative quantitation of over 5000 proteins for each of 100 human plasma samples will be delivered. Data provided shall in parquet files, including study design, experimental conditions, and results fo | Type: Combined Synopsis/Solicitation | Sol#: 75F40
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH
See the Attached Combined Synopsis/Soliciation FDA-CSS-1224787 | Type: Combined Synopsis/Solicitation | Sol#: FDA-CSS-1224787